Showing 1 - 1 results of 1 for search 'RE-ENACT 2 Study Investigators Group', query time: 0.02s Refine Results
  1. 1
    A Multicenter, Retrospective Study (RE-ENACT 2) on Razumab™ (World's First Biosimilar Ranibizumab) in Retinal Vein Occlusion

    A Multicenter, Retrospective Study (RE-ENACT 2) on Razumab™ (World's First Biosimilar Ranibizumab) in Retinal Vein Occlusion by Shashikant Sharma, RE-ENACT 2 Study Investigators Group, Mujtaba Khan, Alok Chaturvedi

    Published 2020-07-01
    Get full text
    Article

Search Tools: